GenMark Projects 52 Percent Growth in Q4 Revenues, Signs $40M Debt Facility

Jan 13, 2015

|

NEW YORK (GenomeWeb) – GenMark yesterday released its preliminary financial results for the fourth quarter of 2014, reporting a 52 percent increase in revenues to $9.8 million for the three months ended Dec. 31, 2014.

The company also said that it had closed a debt facility of up to $40 million led by GE Capital's Healthcare Financial Services business.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Breaking News

The Scan

An Expensive Deal

While gene therapies may have high price tags, they could be cheaper than the cost of managing disease, according to MIT's Technology Review.

Figuring Out Who It'll Work For

Researchers are looking for markers that indicate which cancer patients may respond to immunotherapies, the Associated Press writes.

This Week in Nature

In Nature this week: paternal age associated with de novo mutations in children, and more.

Ye Old P-Value

Nature News writes that researchers are still wrangling over the role of the p-value.

Main menu